We found that GRdim/dim mice challenged with LPS had a significantly increased need of norepinephrine to achieve hemodynamic targets and a more pronounced lactic acidosis during resuscitation measures (“lung-protective” ventilation, fluid resuscitation, and norepinephrine treatment) compared to LPS-challenged GR+/+ mice. The gene discussed is NR3C1; the disease is lactic acidosis.